Five years of nosocomial Gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes

International Journal of Infectious Diseases

Volumn 10, Issue 4, 2006, Pages 320-325

  Sligl, Wendy ^a   Taylor, Geoffrey ^a   Brindley, Peter G ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Bacteremia; Blood stream; Critical illness; Gram negative; Intensive care; Nosocomial infection

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; CORTICOSTEROID; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; IMMUNOSUPPRESSIVE AGENT; MINOCYCLINE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN; TOBRAMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BLOOD CULTURE; CENTRAL VENOUS CATHETERIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENTEROBACTER; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE SEPSIS; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; MEDICAL RECORD; MORTALITY; MULTIPLE TRAUMA; ORGAN TRANSPLANTATION; PNEUMONIA; POSTOPERATIVE PERIOD; PSEUDOMONAS AERUGINOSA; RESPIRATORY FAILURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIOLOGICAL TECHNIQUES; BLOOD; CANADA; CROSS INFECTION; CULTURE MEDIA; DRUG RESISTANCE, BACTERIAL; FEMALE; GRAM-NEGATIVE AEROBIC BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INTENSIVE CARE UNITS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED;

EID: 33744920338     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2005.07.003     Document Type: Article

References (28)

1. Jang T.N., Kuo B.I., Shen S.H., Fung C.P., Lee S.H., Yang T.L., et al. Nosocomial Gram-negative bacteremia in critically ill patients: epidemiologic characteristics and prognostic factors in 147 episodes. J Formos Med Assoc 98 (1999) 465-473
2. Donowitz L.G., Wenzel R.P., and Hoyt J.W. High risk of hospitalized infection in the ICU patient. Crit Care Med 10 (1982) 355-357
3. Wenzel R.P., Thompson R.L., and Landry S.M. Hospital acquired infections in intensive care unit patients: an overview with emphasis on epidemics. Infect Control 4 (1983) 371-375
4. Warren D.K., Zack J.E., Elward A.M., Cox M.J., and Fraser V.J. Nosocomial primary bloodstream infections in intensive care unit patients in a nonteaching community medical center: a 21-month prospective study. Clin Infect Dis 33 (2001) 1329-1335
5. Garrouste-Orgeas M., Chevret S., Mainardi J.L., Timsit J.F., Misset B., and Carlet J. A one-year prospective study of nosocomial bacteremia in ICU and non-ICU patients and the impact on patient outcome. J Hosp Infect 44 (2000) 206-213
6. Salah B.D., Makni S., and Redjeb B.S. Epidemiology of Gram-negative bacterial septicemias: data from Tunisian hospital (1996-1998). Tunis Med 80 (2002) 245-248
7. Harbarth S., Rohner P., Auckenthaler R., Safran E., Sudre P., and Pittet D. Impact and pattern of Gram-negative bacteremia during 6 years at a large university hospital. Scand J Infect Dis 31 (1999) 163-168
8. Valles J., Leon C., and Alvarez-Lerma F. Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC). Clin Infect Dis 24 (1997) 387-395
9. Harbarth S., Ferriere K., Hugonnet S., Ricou B., and Pittet D. Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care. Arch Surg 137 (2002) 1353-1359
10. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definitions for nosocomial infections. APIC infection control and applied epidemiology: principles and practice (1996), Mosby, St. Louis p. A1-A20
11. Wisplinghoff H., Bischoff T., Tallent S.M., Seifert H., Wenzel R.P., and Edmond M.B. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39 (2004) 309-317
12. Rozaidi S.W., Sukro J., and Dan A. The incidence of nosocomial infection in the Intensive Care Unit Hospital Universiti Kebangsaan Malaysia: ICU-acquired nosocomial infection surveillance program. Med J Malaysia 56 (2001) 207-222
13. Bouderka M.A., Bouaggad A., Sahib A., Belabas H., Belbachir M., and Abbassi O. Epidemiologic and prognostic aspects of nosocomial bacteremia in the intensive care unit. Tunis Med 80 (2002) 188-192
14. Jamal W.Y., El-Din K., Rotimi V.O., and Churgh T.D. An analysis of hospital-acquired bacteremia in intensive care unit patients in a university hospital in Kuwait. J Hosp Infect 43 (1999) 49-56
15. Vincent J.L., Bihari D.J., Suter P.M., Bruining H.A., White J., Nicolas-Chanoin M.H., et al. The prevalence of nosocomial infection in the intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) study. JAMA 274 (1995) 639-644
16. Pittet D., Tarara D., and Wenzel R.P. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 271 (1994) 1598-1601
17. Kollef M.H., and Fraser V.J. Antibiotic resistance in the intensive care unit. Ann Intern Med 134 (2001) 298-314
18. Viale P., and Pea F. What is the role of fluoroquinolones in intensive care?. J Chemother 15 Suppl 3 (2003) 5-10
19. Polk R.E., Johnson C.K., McClish D., Wenzel R.P., and Edmond M.B. Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities. Clin Infect Dis 39 (2004) 497-503
20. Ibrahim E.H., Sherman G., Ward S., Fraser V.J., and Kollef M.H. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118 (2000) 9-11
21. Gaynes R. Overview of Gram-negative nosocomial infections. Program and abstracts of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy; 2004 Oct 30-Nov 2; Washington, DC. Abstract 401.
22. Segreti J. Control of resistant Enterobacteriaceae. Program and abstracts of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy; 2004 Oct 30-Nov 2; Washington, DC. Abstract 404.
23. Paul M., Benuri-Silbiger I., Soares-Weiser K., and Leibovici L. Beta-lactam monotherapy versus beta-lactam-aminoglycoside combination therapy for sepsis in immunocompromised patients: systematic review and meta-analysis of randomized trials. BMJ 328 (2004) 668
24. Safdar N., Handelsman J., and Maki D.G. Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis 4 (2004) 519-527
25. Nicholson A.M., Castle D., Akpaka P., Tennant I., and Nelson M. The emergence of Stenotrophomonas maltophilia as a significant nosocomial pathogen at the University Hospital of the West Indies. West Indian Med J 53 (2004) 17-22
26. Villegas M.V., Correa A., Perez F., Miranda M.C., Zuluaga T., and Quinn J.P. Colombian Nosocomial Resistance Study Group. Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals. Diagn Microbiol Infect Dis 49 (2004) 217-222
27. Diekema D.J., Pfaller M.A., Jones R.N., Doern G.V., Winokur P.L., Gales A.C., et al. Survey of bloodstream infections due to Gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program. Clin Infect Dis 29 (1999) 595-607
28. Paterson D.L., Ko W.C., Von Gottberg A., Mohapatra S., Casellas J.M., Goossens H., et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial infections. Ann Intern Med 140 (2004) 26-32